SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-24-039115
Filing Date
2024-03-26
Accepted
2024-03-26 17:24:19
Documents
2
Period of Report
2024-03-25

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm249758-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm249758-1_3seq1.xml 3 1642
2 EXHIBIT 24.1 tm249758d1_ex24-1.htm EX-24.1 8835
  Complete submission text file 0001104659-24-039115.txt   11926
Mailing Address 75 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 75 HAYDEN AVENUE LEXINGTON MA 02421 857-259-5340
Voyager Therapeutics, Inc. (Issuer) CIK: 0001640266 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address VOYAGER THERAPEUTICS, INC. 75 HAYDEN AVENUE LEXINGTON MA 02421
Business Address
Ferguson Toby (Reporting) CIK: 0002015616 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37625 | Film No.: 24784792